Zentalis Pharmaceuticals, Inc. (ZNTL) Earnings
|
Expand Research on ZNTL
| Next EPS Date | 8/12/26 | EPS Growth Rate | -27.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +15.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/26  |
Q226 | N/A | -$0.47 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/12/26 |
Q126 | -$0.50 | -$0.50 | $0.00 | N/A | N/A | N/A |  | | Details | |
| 3/26/26 |
Q425 | N/A | -$0.48 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/25/26 |
Q425 | N/A | -$0.48 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/23/26 |
Q425 | N/A | -$0.48 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/19/26 |
Q425 | N/A | -$0.48 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/18/26 |
Q425 | N/A | -$0.48 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/17/26 |
Q425 | N/A | -$0.48 | N/A | N/A | N/A | N/A | N/A | N/A |
